Hepatitis B school-based vaccination programmes in the USA: a model for hepatitis A and B

被引:8
作者
Koff, RS
机构
[1] Univ Massachusetts, Sch Med, Framingham, MA 01702 USA
[2] MetroW Med Ctr, Dept Med, Framingham, MA 01702 USA
关键词
hepatitis A; hepatitis B; school-based vaccination; high-risk groups;
D O I
10.1016/S0264-410X(99)00471-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Following the recommendation for routine vaccination against hepatitis B virus for newborns, many states have started school-based catch-up vaccination of 11- to 12-year-olds. Implementation of these programmes requires educational and promotional initiatives to increase awareness among parents, children, teachers, school nurses, school boards and administration. Experience in Framingham, Massachusetts, suggests that over 90% of targeted hepatitis B vaccine coverage can be achieved. Because hepatitis B vaccination targeted at high-risk groups in the USA was largely unsuccessful, this suggests that the initial similar targeted approach with hepatitis A vaccination will also fail. Only about 50% of hepatitis A cases have a known risk factor, and multiple high-risk areas exist throughout the USA. However, the geographical clustering of these highrisk areas and the occurrence of periodic outbreaks, suggest that school-based hepatitis A vaccination programmes may be effective in reducing the risk of infection. A voluntary programme in San Antonio achieved 43% of the targeted coverage in its first year, and a compulsory programme is due to start in Oklahoma. The effectiveness of this programme is not yet known, but future recommendations are likely to include hepatitis A vaccination as a school entry requirement in areas with high incidence of hepatitis A. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:S77 / S79
页数:3
相关论文
共 5 条
[1]  
[Anonymous], 1996, MMWR Recomm Rep, V45, P1
[2]   HEPATITIS-B VACCINE - DEMONSTRATION OF EFFICACY IN A CONTROLLED CLINICAL-TRIAL IN A HIGH-RISK POPULATION IN THE UNITED-STATES [J].
SZMUNESS, W ;
STEVENS, CE ;
HARLEY, EJ ;
ZANG, EA ;
OLESZKO, WR ;
WILLIAM, DC ;
SADOVSKY, R ;
MORRISON, JM ;
KELLNER, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (15) :833-841
[3]   A CONTROLLED TRIAL OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE IN HEALTHY-CHILDREN [J].
WERZBERGER, A ;
MENSCH, B ;
KUTER, B ;
BROWN, L ;
LEWIS, J ;
SITRIN, R ;
MILLER, W ;
SHOUVAL, D ;
WIENS, B ;
CALANDRA, G ;
RYAN, J ;
PROVOST, P ;
NALIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (07) :453-457
[4]   Six years' follow-up after hepatitis A vaccination [J].
Werzberger, A ;
Kuter, B ;
Nalin, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (16) :1160-1160
[5]  
1991, MMWR, V40, P1